Your browser doesn't support javascript.
Synergistic influence of air temperature and vaccination on COVID-19 transmission and mortality in 146 countries or regions.
Song, Qifa; Qian, Guoqing; Mi, Yuwei; Zhu, Jianhua; Cao, Chao.
  • Song Q; Medical Data Center, Ningbo City First Hospital, Ningbo, Zhejiang Province, China. Electronic address: qifasong@126.com.
  • Qian G; Department of General Internal Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China.
  • Mi Y; Medical Data Center, Ningbo City First Hospital, Ningbo, Zhejiang Province, China.
  • Zhu J; Department of Critical Care Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China. Electronic address: zhujianhua201107@126.com.
  • Cao C; Department of Respiratory and Critical Medicine, Ningbo City First Hospital, Ningbo, Zhejiang Province, China. Electronic address: caocdoctor@163.com.
Environ Res ; 215(Pt 1): 114229, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2004064
ABSTRACT

OBJECTIVE:

We aimed to determine the influence of vaccination and air temperature on COVID-19 transmission and severity.

METHODS:

The study data in 146 countries from January 6, 2020 to July 28, 2022 were aggregated into 19,856 weeks. Country-level weekly incidence, time-varying reproduction number (Rt), mortality, and infection-fatality ratio (IFR) were compared among groups of these weeks with different vaccination rates and air temperatures.

RESULTS:

Weeks with <15 °C air temperature and 60% vaccination showed the highest incidence (mean, 604; SD, 855; 95% CI, 553-656, unit, /100,000 persons; N = 1073) and the highest rate of weeks with >1 Rt (mean, 41.6%; SD, 1.49%; 95% CI, 39.2-45.2%; N = 1090), while weeks with >25 °C and <20% showed the lowest incidence (mean, 24; SD, 75; 95% CI, 22-26; N = 5805) and the lowest rate of weeks with >1 Rt (mean, 15.3%; SD, 0.461%; 95% CI, 14.2-16.2%; N = 6122). Mortality in weeks with <15 °C (mean, 2.1; SD, 2.8; 95% CI, 2.0-2.2, unit, /100,000 persons; N = 4365) was five times of the mortality in weeks with >25 °C (mean, 0.44; SD, 1; 95% CI, 0.41-0.46; N = 7741). IFR ranged between 2% and 2.6% (SD, 1.9%-2.4%; 95% CI, 2.0-2.7%) at < 20% vaccination level, 1.8% (SD, 2%-2.2%; 95% CI, 1.7-2.0%) at 20-60% vaccination level, and 0.7%-1% (SD, 1%-1.8%; 95% CI, 0.7-1.1%) at > 60% vaccination level and at all air temperatures (all P < 0.001).

CONCLUSIONS:

Vaccination was insufficient to mitigate the transmission since the significantly elevated weekly incidence and >1 Rt rate in weeks with high vaccination, while IFR was reduced by high vaccination. Countries with long-term low air temperature were affected by high transmission and high mortality.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Environ Res Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Topics: Vaccines Limits: Humans Language: English Journal: Environ Res Year: 2022 Document Type: Article